Clinical Trials Browser

Phase 2 × Terminated × alvocidib × Clear all

NCT02520011 2023-11-15

Alvocidib Biomarker-driven Phase 2 AML Study

Phase 2 Terminated

104 enrolled 12 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT03969420 2023-11-09

Study of Alvocidib in Patients With Relapsed/Refractory AML Following Treatment With Venetoclax Combination Therapy

Phase 2 Terminated

11 enrolled 10 charts

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute